SPECIAL NOTICE
65 -- Justification & Approval for Sole Source: Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs)
- Notice Date
- 3/19/2024 3:24:38 PM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
- ZIP Code
- 20705
- Solicitation Number
- 75F40124Q122639J-A
- Response Due
- 3/25/2024 8:00:00 AM
- Archive Date
- 04/09/2024
- Point of Contact
- Suzanne Martella, Phone: 8705437540, Fax: 8705437990
- E-Mail Address
-
suzanne.martella@fda.hhs.gov
(suzanne.martella@fda.hhs.gov)
- Description
- See J&A for Sole Source procurement for�Human induced pluripotent�stem cell-derived Macrophages�(hiPSC-MACs). See also associated Intent to Sole Source and RFQ under notice #:�75F40124Q122639
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/d94e793dfb1a4759b1dba1362f42e097/view)
- Record
- SN07001353-F 20240321/240319230046 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |